Recent Security Class Actions

BioAge Labs, Inc. (NASDAQ: BIOA)

58 Days left to seek lead plaintiff status.

Company Name:BioAge Labs, Inc.
Stock Symbol:NASDAQ: BIOA
Class Period Start:09/26/2024
Class Period End (inclusive):01/07/2025
Filing Deadline:03/10/2025

The Complaint alleges that Plaintiff and the class bought BioAge stock in the initial public offering based on false and/or materially misleading information concerning its STRIDES Phase 2 clinical trial and that these investors sustained damages as a result thereof.

BioAge Labs, Inc. (NASDAQ: BIOA) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.